125 related articles for article (PubMed ID: 16223142)
1. [Antibody treatment of malignant lymphoma].
Tobinai K
Nihon Naika Gakkai Zasshi; 2005 Sep; 94(9):1825-30. PubMed ID: 16223142
[No Abstract] [Full Text] [Related]
2. About the old and the new: gallium-67 scintigraphy to rituximab for lymphoma.
DeNardo GL
Cancer Biother Radiopharm; 1999 Aug; 14(4):235-6. PubMed ID: 10850308
[No Abstract] [Full Text] [Related]
3. [Proteins in haematology].
Clarenbach RE; Mey U
Ther Umsch; 2011 Nov; 68(11):610-7. PubMed ID: 22045523
[TBL] [Abstract][Full Text] [Related]
4. Regression of cutaneous intravascular lymphoma with rituximab.
Han K; Haley JC; Carlson K; Pinter-Brown L; Soriano T
Cutis; 2003 Aug; 72(2):137-40. PubMed ID: 12953938
[TBL] [Abstract][Full Text] [Related]
5. Refractory cold agglutinin-immunohaemolytic anaemia associated to marginal zone lymphoma responding to rituximab.
Petit J; Clavo M; de Sevilla AF; González-Barca E; Domingo-Doménech E; Grañena A
Hematol J; 2003; 4(6):450-1. PubMed ID: 14671620
[TBL] [Abstract][Full Text] [Related]
6. Rituximab for treatment of chemoimmunotherapy naive marginal zone lymphoma.
Lossos IS; Morgensztern D; Blaya M; Alencar A; Pereira D; Rosenblatt J
Leuk Lymphoma; 2007 Aug; 48(8):1630-2. PubMed ID: 17701596
[No Abstract] [Full Text] [Related]
7. [Monoclonal antibodies in hematology in 2009].
Bonnet C; Beguin Y; De Prijck B; Witvrouw N; Hustinx R; Fillet G
Rev Med Liege; 2009; 64(5-6):268-73. PubMed ID: 19642457
[TBL] [Abstract][Full Text] [Related]
8. [Monoclonal antibody treatment of malignant lymphoma].
Buske C; Dreyling M; Unterhalt M; Hiddemann W
Internist (Berl); 2004 Dec; 45(12):1370-7. PubMed ID: 15517123
[TBL] [Abstract][Full Text] [Related]
9. [Malignant lymphoma. Current topics. 1. Antibody therapy].
Izutsu K
Nihon Naika Gakkai Zasshi; 2008 Jul; 97(7):1620-6. PubMed ID: 18720604
[No Abstract] [Full Text] [Related]
10. Severe pulmonary complications after initial treatment with Rituximab for the Asian-variant of intravascular lymphoma.
Wu SJ; Chou WC; Ko BS; Tien HF
Haematologica; 2007 Jan; 92(1):141-2. PubMed ID: 17229654
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody therapy in lymphoid malignancies.
Hainsworth JD
Oncologist; 2000; 5(5):376-84. PubMed ID: 11040273
[TBL] [Abstract][Full Text] [Related]
12. [Monoclonal antibodies in the treatment of malignant lymphoma].
Niu Y; Shi YK
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):435-41. PubMed ID: 16900652
[TBL] [Abstract][Full Text] [Related]
13. Rituximab not affected by statins?
Pharmacogenomics; 2009 Feb; 10(2):259. PubMed ID: 19207027
[No Abstract] [Full Text] [Related]
14. [Monoclonal antibody therapy for non-Hodgkin's lymphoma].
Paul F; Rossi JF; Cartron G
Rev Prat; 2010 Jan; 60(1):59-63. PubMed ID: 20222313
[TBL] [Abstract][Full Text] [Related]
15. Recent therapeutic advances in hematological malignancies: the role of targeted therapies in lymphoma.
Schmitz N
Ann Oncol; 2008 Jul; 19 Suppl 5():v63-7. PubMed ID: 18611903
[No Abstract] [Full Text] [Related]
16. Antilymphoma effects of anti-HLA-DR and CD20 monoclonal antibodies (Lym-1 and Rituximab) on human lymphoma cells.
Liu C; DeNardo G; Tobin E; DeNardo S
Cancer Biother Radiopharm; 2004 Oct; 19(5):545-61. PubMed ID: 15650447
[TBL] [Abstract][Full Text] [Related]
17. Rituximab maintenance for follicular lymphoma.
Vidal L; Gafter-Gvili A; Shpilberg O
Nat Rev Clin Oncol; 2010 Mar; 7(3):1; author reply 1. PubMed ID: 20222179
[No Abstract] [Full Text] [Related]
18. Rituximab immunotherapy for non-Hodgkin's lymphoma.
White CA
Cancer Biother Radiopharm; 1999 Aug; 14(4):241-50. PubMed ID: 10850310
[TBL] [Abstract][Full Text] [Related]
19. New monoclonal antibody approved as lymphoma therapy.
Am J Health Syst Pharm; 1998 Jan; 55(2):110. PubMed ID: 9465971
[No Abstract] [Full Text] [Related]
20. Treatment of localized oral MALT lymphoma by rituximab: a case report.
Yamagata K; Onizawa K; Kojima H; Yoshida H
Oral Maxillofac Surg; 2008 Dec; 12(4):227-30. PubMed ID: 18830723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
